[go: up one dir, main page]

NZ286734A - Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines and medicaments - Google Patents

Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines and medicaments

Info

Publication number
NZ286734A
NZ286734A NZ286734A NZ28673496A NZ286734A NZ 286734 A NZ286734 A NZ 286734A NZ 286734 A NZ286734 A NZ 286734A NZ 28673496 A NZ28673496 A NZ 28673496A NZ 286734 A NZ286734 A NZ 286734A
Authority
NZ
New Zealand
Prior art keywords
alkyl
pyridine
ethyl
pyrazolo
dihydro
Prior art date
Application number
NZ286734A
Other languages
English (en)
Inventor
Allen J Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ286734A publication Critical patent/NZ286734A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ286734A 1995-06-06 1996-06-05 Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines and medicaments NZ286734A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
NZ286734A true NZ286734A (en) 1998-02-26

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ286734A NZ286734A (en) 1995-06-06 1996-06-05 Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines and medicaments

Country Status (43)

Country Link
US (1) US6004974A (de)
EP (1) EP0837860B1 (de)
JP (1) JP3107827B2 (de)
KR (2) KR100191972B1 (de)
CN (1) CN1061044C (de)
AP (1) AP609A (de)
AR (1) AR002745A1 (de)
AT (1) ATE214700T1 (de)
AU (1) AU694871B2 (de)
BG (1) BG62568B1 (de)
BR (1) BR9602627A (de)
CA (1) CA2223624C (de)
CO (1) CO4700460A1 (de)
CZ (1) CZ287251B6 (de)
DE (1) DE69525978T2 (de)
DK (1) DK0837860T3 (de)
DZ (1) DZ2044A1 (de)
ES (1) ES2172583T3 (de)
FI (1) FI114097B (de)
HR (1) HRP960268B1 (de)
HU (1) HUP9601541A3 (de)
IL (1) IL118485A (de)
IS (1) IS1913B (de)
LV (1) LV11620B (de)
MA (1) MA23893A1 (de)
MX (1) MX9709897A (de)
MY (1) MY116527A (de)
NO (1) NO306256B1 (de)
NZ (1) NZ286734A (de)
OA (1) OA10458A (de)
PL (1) PL184195B1 (de)
PT (1) PT837860E (de)
RO (1) RO115881B1 (de)
RU (1) RU2161158C2 (de)
SA (1) SA96170065B1 (de)
SG (1) SG54341A1 (de)
SI (1) SI9600186A (de)
SK (1) SK282167B6 (de)
TN (1) TNSN96083A1 (de)
TR (1) TR199600482A1 (de)
TW (1) TW460469B (de)
WO (1) WO1996039408A1 (de)
YU (1) YU49346B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
EP1380585B1 (de) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinon als Zwischenprodukt
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
ATE320800T1 (de) 1999-08-21 2006-04-15 Altana Pharma Ag Synergistische kombination von roflumilast und salmeterol
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
DE60216588T2 (de) * 2001-05-25 2007-09-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
WO2002096463A1 (en) * 2001-05-25 2002-12-05 Pfizer Inc. A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
EP1624893A2 (de) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Phosphodiesterase inhibitoren in der unfruchtbarkeit
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
SI2363130T1 (sl) 2006-07-05 2014-09-30 Takeda Gmbh Kombinacija inhibitorjev HMG-CoA reduktaze atorvastatina ali simvastatina z inhibitorjem fosfodiesteraze 4, kot je roflumilast, za zdravljenje vnetnih pljučnih bolezni
WO2010043676A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
WO2011067145A1 (en) 2009-12-04 2011-06-09 Nerviano Medical Sciences S.R.L. Tricyclopyrazole derivatives
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
EP0707585A1 (de) * 1993-07-06 1996-04-24 Pfizer Inc. Bicyclische tetrahydropyrazolopyridine
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
ATE214700T1 (de) 2002-04-15
DK0837860T3 (da) 2002-05-27
SK71896A3 (en) 1997-05-07
PL314459A1 (en) 1996-12-09
AR002745A1 (es) 1998-04-29
CN1142499A (zh) 1997-02-12
KR970003440A (ko) 1997-01-28
ES2172583T3 (es) 2002-10-01
HU9601541D0 (en) 1996-07-29
AP9600806A0 (en) 1996-07-31
YU34696A (sh) 1999-07-28
TR199600482A1 (tr) 1997-03-21
AP609A (en) 1997-09-03
EP0837860B1 (de) 2002-03-20
IS4350A (is) 1996-12-07
DE69525978D1 (de) 2002-04-25
PL184195B1 (pl) 2002-09-30
JP3107827B2 (ja) 2000-11-13
NO962320L (no) 1996-12-09
TNSN96083A1 (fr) 2005-03-15
BG100640A (bg) 1997-03-31
CA2223624C (en) 2001-02-20
MA23893A1 (fr) 1996-12-31
NO306256B1 (no) 1999-10-11
FI974434A0 (fi) 1997-12-05
BG62568B1 (bg) 2000-02-29
BR9602627A (pt) 1998-09-01
JPH10510242A (ja) 1998-10-06
LV11620B (en) 1997-04-20
HUP9601541A2 (en) 1997-02-28
RU2161158C2 (ru) 2000-12-27
AU5477396A (en) 1996-12-19
US6004974A (en) 1999-12-21
CO4700460A1 (es) 1998-12-29
RO115881B1 (ro) 2000-07-28
IL118485A0 (en) 1996-09-12
HRP960268B1 (en) 2002-12-31
KR100225719B1 (en) 1999-10-15
SK282167B6 (sk) 2001-11-06
CZ287251B6 (en) 2000-10-11
IL118485A (en) 2000-02-17
TW460469B (en) 2001-10-21
CN1061044C (zh) 2001-01-24
OA10458A (en) 2002-03-27
DZ2044A1 (fr) 2002-07-21
NO962320D0 (no) 1996-06-05
EP0837860A1 (de) 1998-04-29
MY116527A (en) 2004-02-28
FI974434L (fi) 1997-12-05
LV11620A (lv) 1996-12-20
CA2223624A1 (en) 1996-12-12
WO1996039408A1 (en) 1996-12-12
HUP9601541A3 (en) 1997-05-28
HRP960268A2 (en) 1997-08-31
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
CZ162696A3 (en) 1997-01-15
KR100191972B1 (ko) 1999-06-15
AU694871B2 (en) 1998-07-30
IS1913B (is) 2004-02-03
FI114097B (fi) 2004-08-13
SI9600186A (en) 1997-04-30
YU49346B (sh) 2005-07-19
DE69525978T2 (de) 2002-12-19
SG54341A1 (en) 1998-11-16
MX9709897A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
NZ286734A (en) Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines and medicaments
CA2166721C (en) Bicyclic tetrahydro pyrazolopyridines
EP0850215B1 (de) N-aroyl-glycin-hydroxamsäure-derivate und verwandte verbindungen
AU2007275816A1 (en) 1-hydroxy naphthyridine compounds as anti-HIV agents
JP7148709B2 (ja) バニン阻害剤としてのヘテロ芳香族化合物
CN105492434A (zh) Rorc2抑制剂及其使用方法
AU2011246553B2 (en) Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
AU7091098A (en) Compounds
EP3890828A1 (de) Heteroaromatische verbindungen als vanininhibitoren
AP932A (en) Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
AU7091198A (en) Compounds
NZ620037B2 (en) Tricyclic heterocyclic compounds and jak inhibitors
NZ709835A (en) Tricyclic heterocyclic compounds and jak inhibitors
NZ709835B2 (en) Tricyclic heterocyclic compounds and jak inhibitors
UA45961C2 (uk) ТРИЦИКЛІЧНІ 5,6-ДИГІДРО-9Н-ПІРАЗОЛО[3,4-с]-1,2,4-ТРИАЗОЛО[4,3-а]ПІРИДИНИ, СПОСІБ ІНГІБУВАННЯ ФОСФОДІЕСТЕРАЗИ (PDE) ТИПУ IV, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)